1.Preoperative embolization and en bloc resection of a metastatic pheochromocytoma of the cervical spine
Aman SINGH ; Gabrielle SANTANGELO ; Nathaniel ELLENS ; Gurkirat KOHLI ; Robert PRANAAT ; Matthew T. BENDER
Journal of Cerebrovascular and Endovascular Neurosurgery 2024;26(3):331-337
This is a unique case of metastatic pheochromocytoma of the cervical spine treated with preoperative embolization and subsequent en bloc resection. A 65-year-old man with metastatic pheochromocytoma presented with two weeks of worsening neck pain, left arm and leg weakness and paresthesia, and urinary incontinence. Magnetic resonance imaging showed a metastatic osseous lesion at C6 with severe stenosis and spinal cord compression. The patient underwent successful preoperative angiographic embolization with a liquid embolic agent followed by C5-C7 laminectomy, en bloc tumor resection, and C3-T2 posterior spinal fusion. Six weeks postoperatively, the patient reported improving strength and resolving neck pain and paresthesias. While there is no standard paradigm for the treatment of metastatic pheochromocytomas of the cervical spine, preoperative embolization may minimize intraoperative blood loss and hemodynamic instability during subsequent surgical resection.
2.Preoperative embolization and en bloc resection of a metastatic pheochromocytoma of the cervical spine
Aman SINGH ; Gabrielle SANTANGELO ; Nathaniel ELLENS ; Gurkirat KOHLI ; Robert PRANAAT ; Matthew T. BENDER
Journal of Cerebrovascular and Endovascular Neurosurgery 2024;26(3):331-337
This is a unique case of metastatic pheochromocytoma of the cervical spine treated with preoperative embolization and subsequent en bloc resection. A 65-year-old man with metastatic pheochromocytoma presented with two weeks of worsening neck pain, left arm and leg weakness and paresthesia, and urinary incontinence. Magnetic resonance imaging showed a metastatic osseous lesion at C6 with severe stenosis and spinal cord compression. The patient underwent successful preoperative angiographic embolization with a liquid embolic agent followed by C5-C7 laminectomy, en bloc tumor resection, and C3-T2 posterior spinal fusion. Six weeks postoperatively, the patient reported improving strength and resolving neck pain and paresthesias. While there is no standard paradigm for the treatment of metastatic pheochromocytomas of the cervical spine, preoperative embolization may minimize intraoperative blood loss and hemodynamic instability during subsequent surgical resection.
3.Preoperative embolization and en bloc resection of a metastatic pheochromocytoma of the cervical spine
Aman SINGH ; Gabrielle SANTANGELO ; Nathaniel ELLENS ; Gurkirat KOHLI ; Robert PRANAAT ; Matthew T. BENDER
Journal of Cerebrovascular and Endovascular Neurosurgery 2024;26(3):331-337
This is a unique case of metastatic pheochromocytoma of the cervical spine treated with preoperative embolization and subsequent en bloc resection. A 65-year-old man with metastatic pheochromocytoma presented with two weeks of worsening neck pain, left arm and leg weakness and paresthesia, and urinary incontinence. Magnetic resonance imaging showed a metastatic osseous lesion at C6 with severe stenosis and spinal cord compression. The patient underwent successful preoperative angiographic embolization with a liquid embolic agent followed by C5-C7 laminectomy, en bloc tumor resection, and C3-T2 posterior spinal fusion. Six weeks postoperatively, the patient reported improving strength and resolving neck pain and paresthesias. While there is no standard paradigm for the treatment of metastatic pheochromocytomas of the cervical spine, preoperative embolization may minimize intraoperative blood loss and hemodynamic instability during subsequent surgical resection.
4.Preoperative embolization and en bloc resection of a metastatic pheochromocytoma of the cervical spine
Aman SINGH ; Gabrielle SANTANGELO ; Nathaniel ELLENS ; Gurkirat KOHLI ; Robert PRANAAT ; Matthew T. BENDER
Journal of Cerebrovascular and Endovascular Neurosurgery 2024;26(3):331-337
This is a unique case of metastatic pheochromocytoma of the cervical spine treated with preoperative embolization and subsequent en bloc resection. A 65-year-old man with metastatic pheochromocytoma presented with two weeks of worsening neck pain, left arm and leg weakness and paresthesia, and urinary incontinence. Magnetic resonance imaging showed a metastatic osseous lesion at C6 with severe stenosis and spinal cord compression. The patient underwent successful preoperative angiographic embolization with a liquid embolic agent followed by C5-C7 laminectomy, en bloc tumor resection, and C3-T2 posterior spinal fusion. Six weeks postoperatively, the patient reported improving strength and resolving neck pain and paresthesias. While there is no standard paradigm for the treatment of metastatic pheochromocytomas of the cervical spine, preoperative embolization may minimize intraoperative blood loss and hemodynamic instability during subsequent surgical resection.
5.Safety and efficacy comparison of embolic agents for middle meningeal artery embolization for chronic subdural hematoma
Nathaniel R. ELLENS ; Derrek SCHARTZ ; Gurkirat KOHLI ; Redi RAHMANI ; Sajal Medha K. AKKIPEDDI ; Thomas K. MATTINGLY ; Tarun BHALLA ; Matthew T. BENDER
Journal of Cerebrovascular and Endovascular Neurosurgery 2024;26(1):1-12
Objective:
To perform a systematic review and meta-analysis evaluating the efficacy of middle meningeal artery embolization in terms of both clinical and radiographic outcomes, when performed with different embolic agents.
Methods:
A systematic literature review and meta-analysis was performed to evaluate the impact of embolic agents on outcomes for middle meningeal artery (MMA) embolization. The use of polyvinyl alcohol (PVA) with or without (±) coils, N-butyl cyanoacrylate (n-BCA) ± coils, and Onyx alone were separately evaluated. Primary outcome measures were recurrence, the need for surgical rescue and in-hospital periprocedural complications.
Results:
Thirty-one studies were identified with a total of 1,134 patients, with 786 receiving PVA, 167 receiving n-BCA, and 181 patients receiving Onyx. There was no difference in the recurrence rate (5.5% for PVA, 4.5% for n-BCA, and 6.5% for Onyx, with P=0.71) or need for surgical rescue (5.0% for PVA, 4.0% for n-BCA, and 6.9% for Onyx, with P=0.89) based on the embolic agent. Procedural complications also did not differ between embolic agents (1.8% for PVA, 3.6% for n-BCA, and 1.6% for Onyx, with P=0.48).
Conclusions
Rates of recurrence, need for surgical rescue, and periprocedural complication following MMA embolization are not impacted by the type of embolic agent utilized. Ongoing clinical trials may be used to further investigate these findings.